(Q35983167)

11 August 2017

ChlVPP combination chemotherapy for Hodgkin's disease: long-term results (English)

1 reference

11 August 2017

1 reference

Selby P

1

1 reference

11 August 2017

Patel P

2

1 reference

11 August 2017

Milan S

3

1 reference

11 August 2017

Meldrum M

4

1 reference

11 August 2017

Mansi J

5

1 reference

11 August 2017

Mbidde E

6

1 reference

11 August 2017

Brada M

7

1 reference

11 August 2017

Perren T

8

1 reference

11 August 2017

Forgeson G

9

1 reference

11 August 2017

Gore M

10

1 reference

11 August 2017

language of work or name

English

0 references

publication date

1 August 1990

1 reference

full work available at URL

11 August 2017

http://eprints.whiterose.ac.uk/100584/

content deliverer

White Rose Research Online

copyright license

Creative Commons Attribution-NonCommercial-ShareAlike

0 references

published in

British Journal of Cancer

1 reference

11 August 2017

62

1 reference

11 August 2017

2

1 reference

11 August 2017

279-285

1 reference

https://scigraph.springernature.com/pub.10.1038/bjc.1990.278

11 August 2017

0 references

cites work

Five years' experience with ChlVPP: effective low-toxicity combination chemotherapy for Hodgkin's disease

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1971832

Curability of advanced Hodgkin's disease with chemotherapy. Long-term follow-up of MOPP-treated patients at the National Cancer Institute

2 October 2017

2 references

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1971832

2 October 2017

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1971832

Chemotherapy and irradiation in childhood Hodgkin's disease

24 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1971832

Report of the Committee on Hodgkin's Disease Staging Classification

2 October 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1971832

Twenty years of MOPP therapy for Hodgkin's disease

2 October 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1971832

Prognostic factors for survival in stage IIIB and IV Hodgkin's disease: a multivariate analysis comparing two specialist treatment centres

2 October 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1971832

High dose melphalan, BCNU and etoposide with autologous bone marrow transplantation for Hodgkin's disease

2 October 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1971832

A combination of chlorambucil, vinblastine, procarbazine and prednisolone for treatment of Hodgkin's disease

2 October 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1971832

Design and analysis of randomized clinical trials requiring prolonged observation of each patient. II. analysis and examples

2 October 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1971832

BCVPP chemotherapy for advanced Hodgkin's disease: evidence for greater duration of complete remission, greater survival, and less toxicity than with a MOPP regimen. Results of the Eastern Cooperative Oncology Group study

2 October 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1971832

The pathology and nomenclature of Hodgkin's disease.

24 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1971832

Risk of second cancers after treatment for Hodgkin's disease

24 September 2018

1 reference

PubMed

https://pubmed.ncbi.nlm.nih.gov/2386744

12 December 2020

inferred from PubMed ID database lookup

ChlVPP chemotherapy in advanced Hodgkin's disease

1 reference

PubMed

https://pubmed.ncbi.nlm.nih.gov/2386744

12 December 2020

inferred from PubMed ID database lookup

Treatment of advanced Hodgkin's disease with high dose melphalan and autologous bone marrow transplantation

1 reference

PubMed

https://pubmed.ncbi.nlm.nih.gov/2386744

12 December 2020

inferred from PubMed ID database lookup

Identifiers

DOI

10.1038/BJC.1990.278

1 reference

Dimensions Publication ID

11 August 2017

1023189695

0 references

Fatcat ID

release_hsnnbxetirfrtdq55jnykgi54q

1 reference

Fatcat

https://api.fatcat.wiki/v0/release/hsnnbxetirfrtdq55jnykgi54q

24 November 2022

mapped directly with Wikidata item

1 reference

11 August 2017

PubMed publication ID

2386744

1 reference